Piramal Critical Care ropes in Jeffrey Hampton as President, COO
Mumbai: Piramal Pharma Limited’s Piramal Critical Care (PCC) business has announced the appointment of Jeffrey Hampton as President & Chief Operating Officer (COO).
For his new role, Mr. Hampton will be based in the United States. A Bachelor of Science in Marketing from University of Florida, Mr. Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm’s growth strategy.
Prior to that, he was the Senior Vice President and General Manager at Apotex for the US and Latin America regions. At Apotex, Mr. Hampton restructured the US commercial team to maximize efficiency and established procedures for identifying and executing life cycle management practices to improve profitability and market penetration. His career, so far, spans over three decades across sales and marketing, regulatory, commercial operations, sales strategy, distribution, and business development. Mr. Hampton has also worked with several leading pharmaceutical companies, including Osmotica Pharmaceuticals, Dabur Pharma and IVAX Pharmaceuticals.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.